When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

The study focuses on how immune cells react to amyloid-beta (Aβ) plaques, a hallmark of Alzheimer's, and how this immune ...

It's pretty clear at this point that the latest class of ... an anti-amyloid therapy," said Matthew Schrag, a Vanderbilt neurology professor and director of the Cerebral Amyloid Angiopathy Clinic.

Of the company’s eight pipeline assets, the most advanced, a first-in-class therapy ... CAA, for example, people with more than four microbleeds, are not eligible for anti-amyloid monoclonal ...

The announcement highlights LEQEMBI's dual mechanism in combating Alzheimer's by clearing both protofibrils and amyloid ... therapy or patients with findings on MRI that are suggestive of CAA.